Class III · Low risk
Buprenorphine Transdermal System
Failed Impurities/Degradation Specifications: Out of specification for related substance 10-hydroxy buprenorphine N-Oxide results generated at the 18-month stability timepoint.
National Drug Code
Is NDC 60505-7077-05 recalled?
Buprenorphine Transdermal System
Yes — this exact package was recalled
1 FDA recall names the code 60505-7077-05 directly. A recall still applies to particular lot numbers — compare the lot on your package with the FDA notice below, and talk to your pharmacist before stopping a prescribed medication.
This code is not in the current FDA NDC directory — usual for a product that has since been discontinued or repackaged. The details below come from the recall notices themselves.
Recalls naming this package
Where to find this code. The NDC is printed on the pharmacy label and on the manufacturer's carton, usually as three groups of digits after “NDC”. The last group is the package size — two bottles of the same medicine can differ only in that group, and a recall may cover one but not the other.
Other recalled products from this labeler
- 60505-0589 Brimonidine Tartrate/Timolol Maleate Ophthalmic Solution 3
- 60505-0829 Fluticasone Propionate 3
- 60505-2580 Atorvastatin Calcium 3
- 60505-0595 See recall 2
- 60505-0596 See recall 2
- 60505-0773 See recall 2
Free recall alerts
Know the day your medication is recalled
Tell us what you take. When FDA posts a recall announcement or classifies a recall for one of your medications, we email you in plain English, with what to check. No account needed.